Genelux Stock Quote GNLX - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

3.17

Bid

3.12

Ask

3.25

Volume

108,737

3.16 Day's Range 3.5999

3.07 52 Week Range 40.98

Market Cap

84.428M

Previous Close

3.40

Open

3.45

Last Trade

3.25

Last Trade Time

16:20:31

Financial Volume

$ 363,969

VWAP

3.3472

Average Volume (3m)

143,373

Shares Outstanding

26,717,676

Dividend Yield

PE Ratio

-2.98

Earnings Per Share (EPS)

-1.06

Revenue

170k

Net Profit

-28.3M

Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec, a proprietary, modified strain of the vac... Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec, a proprietary, modified strain of the vaccinia virus for the treatment of ovarian cancer and non-small-cell lung cancer. The company is also developing V2ACT Immunotherapy for the treatment of pancreatic cancer; and V-VET1, an animal health product candidate. It has a licensing agreement with ELIAS Animal Health, LLC. Genelux Corporation was incorporated in 2001 and is headquartered in Westlake Village, California. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.genelux.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Genelux Corporation is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker GNLX. The last closing price for Genelux was $3.40. Over the last year, Genelux shares have traded in a share price range of $ 3.07 to $ 40.98.

Genelux currently has 26,717,676 shares outstanding. The market capitalization of Genelux is $84.43 million. Genelux has a price to earnings ratio (PE ratio) of -2.98.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-1.02	-24.3436754177	4.19	4.22	3.07	156097	3.39195921	CS
4	-3.33	-51.2307692308	6.5	6.5	3.07	147041	4.09237386	CS
12	-6.83	-68.3	10	10	3.07	143373	6.25956545	CS
26	-9.78	-75.5212355212	12.95	18.01	3.07	130545	9.53355831	CS
52	-20.66	-86.6974402014	23.83	40.98	3.07	131322	17.02130655	CS
156	-2.83	-47.1666666667	6	40.98	3.07	130930	17.7477028	CS
260	-2.83	-47.1666666667	6	40.98	3.07	130930	17.7477028	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CYCCCyclacel Pharmaceuticals Inc	$ 2.03 (49.26%)	571.09k
MRINMarin Software Incorporated	$ 3.5601 (36.40%)	1.53M
WGSGeneDx Holdings Corporation	$ 14.04 (27.64%)	21.66k
TTNPTitan Pharmaceuticals Inc	$ 8.40 (22.63%)	186
MULNMullen Automotive Inc	$ 6.95 (21.50%)	4.75M
CACOCaravelle International Group	$ 0.8519 (-13.88%)	256.36k
EKSOEkso Bionics Holdings Inc	$ 1.13 (-12.40%)	10.59k
CSSEChicken Soup for the Soul Entertainment Inc	$ 0.268 (-10.76%)	200.99k
QLIQilian International Holding Group Ltd	$ 0.741 (-10.16%)	120.24k
AAGRAfrican Agriculture Holdings Inc	$ 0.3053 (-9.65%)	2.42k
CRKNCrown Electrokinetics Corporation	$ 0.0549 (8.71%)	8.93M
MULNMullen Automotive Inc	$ 6.96 (21.68%)	4.75M
PARAParamount Global	$ 12.36 (0.90%)	2.86M
TSLATesla Inc	$ 193.40 (-0.33%)	2.24M
VXUSVanguard Total International Stock	$ 59.71 (0.00%)	2.18M